Viridian Therapeutics, Inc. Tech Stack
Clinical-stage biotech developing antibody therapies for autoimmune disease
Viridian is a public biopharmaceutical company advancing multiple candidates through Phase 3 trials, with two programs in thyroid eye disease and a portfolio of FcRn inhibitors across autoimmune indications. The tech stack reflects a mid-to-late stage clinical operator: heavy on Veeva (clinical data management, safety, submission), SAS and JMP (statistical programming), IQVIA (trial operations), plus AWS infrastructure (Kubernetes, Terraform). Current hiring acceleration focuses on senior biostatistics, medical direction, and data roles — suggesting the company is ramping analytics and regulatory submissions as Phase 3 trials mature.
Tech Stack 22 technologies
What Viridian Therapeutics, Inc. Is Building
◆Challenges
- Inspection readiness
- Vendor management and oversight
- Managing global clinical trial timelines
- Delivering statistical analysis on time
- Optimizing distribution for rare disease therapies
- Ensuring compliance with drug distribution regulations
- Study schedule and budget adherence
- Complex issue resolution in trials
- Improving accounting close processes
- Enhancing financial controls
▲Active Projects
- System implementations for accounting
- Regulatory submission support
- Scalable distribution model design
- Statistical programming implementation
- Inventory optimization via channel data analysis
- Developing standard processes and document templates
- Supporting inspection readiness activities
- Aligning clinical development processes across programs
- Sec reporting compliance
- Audit timeline management
Hiring Activity
Department
Seniority
Notable leadership hires: Medical Director, Biostatistics Director